Trial of Prasinezumab in Early-Stage Parkinson's Disease.
N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867.
N Engl J Med. 2022.
PMID: 35921451
Clinical Trial.